COVID-19-induced silent myocarditis and newly developed hypertension in a 3-year-old boy.
Elaheh Malakan RadSara MomtazmaneshPublished in: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology (2022)
COVID-19 can induce silent myocarditis with progression to dilated cardiomyopathy and newly developed systemic hypertension. Thus, a thorough examination of the heart and measurement of blood pressure are mandatory in every child with COVID-19 infection. Cardiac MR is an indispensable tool in the diagnosis, follow-up, and prognostication of COVID-19 myocarditis. Moreover, four-chamber speckle tracking strain imaging showed apical rocking in all the four heart chambers in this child with opposite direction in the failed left ventricle compared with other cardiac chambers. Lastly, the presence of septal flash on M-mode echocardiography, apical rocking and prestretch-rebound stretch patterns on longitudinal strain imaging of the failed left ventricle in this child may be of predictive value for response to cardiac resynchronization therapy.
Keyphrases
- blood pressure
- coronavirus disease
- left ventricular
- sars cov
- cardiac resynchronization therapy
- heart failure
- mental health
- pulmonary hypertension
- high resolution
- mitral valve
- hypertrophic cardiomyopathy
- hypertensive patients
- pulmonary artery
- heart rate
- respiratory syndrome coronavirus
- computed tomography
- type diabetes
- high glucose
- magnetic resonance imaging
- diabetic rats
- cross sectional
- mass spectrometry
- metabolic syndrome
- insulin resistance
- adipose tissue
- pulmonary arterial hypertension
- endothelial cells